SEARCH TIPS
Search term too short
Invalid text in search term. Try again
ADVANCED SEARCH
DOCKET SEARCH
Search
Toggle navigation
OPINIONS
Opinions of the Court
Opinions Relating to Orders
In-Chambers Opinions
U. S. Reports
Online Sources Cited in Opinions
Media Files Cited in Opinions
Case Citation Finder
FILING & RULES
Electronic Filing
Rules and Guidance
Supreme Court Bar
ORAL ARGUMENTS
Argument Transcripts
Argument Audio
Calendars and Lists
Courtroom Seating
CASE DOCUMENTS
Docket Search
Orders of the Court
Orders by Circuit
Granted/Noted Cases List
Journal
NEWS MEDIA
Services for News Media
Press Releases
Media Advisories
Press Credentials
Speeches
A Reporter's Guide to Applications
Chief Justice's Year-End Reports on the Federal Judiciary
ABOUT
Justices
Supreme Court at Work
Code of Conduct for Justices
History and Traditions
The Supreme Court Building
Building Regulations
Frequently Asked Questions
VISIT
Hours & Directions
Prohibited Items
Accessibility
What Can I See and Do?
Exhibitions
Activities for Students & Families
Maps & Brochures
Student Group Visits
Etiquette
Café & Building Amenities
Home
>
Search Results
Docket for 20-779
Search documents in this case:
Search
No. 20-779
Title:
Argentum Pharmaceuticals LLC, Petitioner
v.
Novartis Pharmaceuticals Corporation
Docketed:
December 8, 2020
Lower Ct:
United States Court of Appeals for the Federal Circuit
Case Numbers:
(2018-2273)
Decision Date:
April 23, 2020
Rehearing Denied:
July 9, 2020
Discretionary Court Decision Date:
Date
Proceedings and Orders
Dec 04 2020
Petition for a writ of certiorari filed. (Response due January 7, 2021)
Petition
Certificate of Word Count
Proof of Service
Dec 22 2020
Waiver of right of respondent Novartis Pharmaceuticals Corporation to respond filed.
Main Document
Jan 06 2021
DISTRIBUTED for Conference of 1/22/2021.
Jan 07 2021
Brief amicus curiae of Jonathan Stroud filed. (Distributed)
Main Document
Proof of Service
Certificate of Word Count
Jan 14 2021
Response Requested. (Due February 16, 2021)
Feb 16 2021
Brief of respondent Novartis Pharmaceuticals Corporation in opposition filed.
Main Document
Other
Certificate of Word Count
Proof of Service
Mar 03 2021
DISTRIBUTED for Conference of 3/19/2021.
Mar 03 2021
Reply of petitioner Argentum Pharmaceuticals LLC filed. (Distributed)
Main Document
Certificate of Word Count
Proof of Service
Mar 22 2021
Petition DENIED.
NAME
ADDRESS
PHONE
Attorneys for Petitioner
Teresa Stanek Rea
Counsel of Record
Crowell & Moring LLP
1001 Pennsylvania Ave., N.W.
Washington, DC 20004-2595
trea@crowell.com
2026242620
Party name: Argentum Pharmaceuticals LLC
Attorneys for Respondent
Mark Andrew Perry
Counsel of Record
Gibson Dunn & Crutcher, LLP
1050 Connecticut Avenue, NW
Washington, DC 20036
mperry@gibsondunn.com
202-887-3667
Party name: Novartis Pharmaceuticals Corporation
Other
Jonathan Rudolph Kominek Stroud
Counsel of Record
Unified Patents, LLC
1875 Connecticut Ave., NW Floor 10
Washington, DC 20009
jonathan@unifiedpatents.com
202-805-8931
Party name: Jonathan Stroud
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##